PSKW Revenue and Competitors
Estimated Revenue & Valuation
- PSKW's estimated annual revenue is currently $7.8M per year.
- PSKW's estimated revenue per employee is $200,000
Employee Data
- PSKW has 39 Employees.
- PSKW grew their employee count by 0% last year.
PSKW's People
Name | Title | Email/Phone |
---|---|---|
1 | Senior Director New Business Development - Western US | Reveal Email/Phone |
2 | Project Manager | Reveal Email/Phone |
3 | President | Reveal Email/Phone |
PSKW Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $25.8M | 101 | 10% | N/A | N/A |
#2 | $13.1M | 57 | 19% | N/A | N/A |
#3 | $6M | 30 | 0% | N/A | N/A |
#4 | $4M | 22 | 0% | N/A | N/A |
#5 | $20.8M | 83 | 12% | N/A | N/A |
#6 | $11.7M | 52 | -16% | N/A | N/A |
#7 | $143.4M | 459 | N/A | N/A | N/A |
#8 | $3.5M | 20 | 0% | N/A | N/A |
#9 | $1M | 8 | N/A | N/A | N/A |
#10 | $5.1M | 29 | -26% | N/A | N/A |
What Is PSKW?
From co-pay incentive cards, vouchers, and coupons to leading-edge digital and mobile adherence marketing techniques, PSKW is the market leader and innovation driver in pharmaceutical loyalty relationship marketing. The PSKW team works as a strategic partner with brand teams to effectively and efficiently build trial, compliance, and adherence. PSKW helps brand teams accomplish key business objectives: • Creating more brand-loyal patients • Driving top line growth • Acquiring new patients • Providing access to hard-to-reach prescribers • Increasing number of prescribers responding to details Ready to talk? Email Chris Dowd at [email protected].
keywords:N/AN/A
Total Funding
39
Number of Employees
$7.8M
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $7.3M | 40 | 33% | N/A |
#2 | $8.1M | 48 | 30% | N/A |
#3 | $8.1M | 62 | 35% | N/A |
#4 | $21.3M | 84 | 18% | N/A |
#5 | $7.5M | 86 | -5% | $11.5M |